Evoke Wealth LLC Boosts Stock Position in CME Group Inc. (NASDAQ:CME)

Evoke Wealth LLC lifted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 0.4% in the 4th quarter, HoldingsChannel reports. The firm owned 24,673 shares of the financial services provider’s stock after purchasing an additional 101 shares during the quarter. Evoke Wealth LLC’s holdings in CME Group were worth $5,873,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Raymond James Financial Inc. purchased a new position in CME Group during the 4th quarter worth approximately $871,063,000. Franklin Resources Inc. increased its stake in shares of CME Group by 70.4% in the third quarter. Franklin Resources Inc. now owns 2,427,107 shares of the financial services provider’s stock worth $544,157,000 after acquiring an additional 1,003,119 shares during the period. Capital Wealth Planning LLC raised its holdings in shares of CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider’s stock worth $565,671,000 after purchasing an additional 996,498 shares during the last quarter. Egerton Capital UK LLP acquired a new position in CME Group during the fourth quarter valued at $223,967,000. Finally, Canoe Financial LP boosted its holdings in CME Group by 698.0% in the fourth quarter. Canoe Financial LP now owns 544,219 shares of the financial services provider’s stock valued at $126,384,000 after purchasing an additional 476,019 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $263.58 on Tuesday. The business’s 50 day moving average price is $243.56 and its 200 day moving average price is $232.93. The company has a market cap of $94.98 billion, a price-to-earnings ratio of 27.26, a PEG ratio of 6.76 and a beta of 0.53. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. CME Group Inc. has a one year low of $190.70 and a one year high of $264.95.

CME Group (NASDAQ:CMEGet Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. On average, research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group declared that its board has authorized a share repurchase plan on Thursday, December 5th that permits the company to repurchase $3.00 billion in shares. This repurchase authorization permits the financial services provider to purchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its stock is undervalued.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be paid a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 1.90%. CME Group’s dividend payout ratio is presently 51.71%.

Insider Transactions at CME Group

In other news, insider Julie Winkler sold 11,592 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares in the company, valued at $5,453,085.45. The trade was a 34.63 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Howard J. Siegel sold 10,000 shares of CME Group stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the transaction, the director now directly owns 21,873 shares of the company’s stock, valued at approximately $5,686,980. This represents a 31.37 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 27,076 shares of company stock valued at $6,871,496. 0.30% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CME. Keefe, Bruyette & Woods lifted their price objective on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research note on Friday, February 14th. Oppenheimer lifted their price target on CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Barclays boosted their price target on CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a report on Thursday, February 13th. Royal Bank of Canada raised their price objective on shares of CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 13th. Finally, Raymond James upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price for the company in a research note on Monday, March 10th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, CME Group currently has a consensus rating of “Hold” and a consensus target price of $238.93.

Check Out Our Latest Stock Report on CME Group

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.